| 20.16 0.41 (2.08%) | 06-12 16:00 | |||||||||||||
|
|
| Short term | ||||
| Mid term | |
|||
| Targets | 6-month : | 24.43 | 1-year : | 25.89 |
| Resists | First : | 20.92 | Second : | 22.17 |
| Pivot price | 20.57 |
|||
| Supports | First : | 18.9 | Second : | 15.72 |
| MAs | MA(5) : | 19.59 |
MA(20) : | 20.38 |
| MA(100) : | 18.3 |
MA(250) : | 17.01 |
|
| MACD | MACD : | -0.1 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 26.3 |
D(3) : | 19.8 |
| RSI | RSI(14): 50.4 |
|||
| 52-week | High : | 22.48 | Low : | 12.17 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ PSIL ] has closed above bottom band by 38.1%. Bollinger Bands are 51.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 20.31 - 20.39 | 20.39 - 20.47 |
| Low: | 19.35 - 19.44 | 19.44 - 19.52 |
| Close: | 20.01 - 20.16 | 20.16 - 20.29 |
This actively managed Exchange Traded Fund (ETF) endeavors to meet its investment goals by typically allocating a minimum of 80% of its total net assets (including any capital secured through borrowing for investment purposes) into the securities of specific companies. To be eligible for inclusion, these companies must either derive at least half of their net revenue from, or commit 50% or more of their assets to, psychedelic compounds, their derivatives, or other financial instruments exhibiting similar economic characteristics. The fund's primary holdings consist of publicly traded life sciences firms focused on psychedelic medical treatments, in addition to other businesses involved in the broader psychedelics sector. It is important to note that this fund maintains a concentrated, non-diversified portfolio.
Tue, 09 Jun 2026
Trading Systems Reacting to (PSIL) Volatility - Stock Traders Daily
Fri, 29 May 2026
How Advisorshares Psychedelics Etf (PSIL) Affects Rotational Strategy Timing - Stock Traders Daily
Thu, 28 May 2026
Watch Drilldown: AdvisorShares Psychedelics ETF - Bloomberg.com
Mon, 27 Apr 2026
AdvisorShares Psychedelics ETF (PSIL) News - The Daily Upside
Sun, 26 Apr 2026
New Executive Orders Boost Weed and Psilocybin ETFs - Yahoo Finance
Fri, 24 Apr 2026
Executive Order Sparks New Phase for Psychedelic Biotech, Risks Remain - Investing News Network
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |